AMOXICILLIN AND CLAVULANATE POTASSIUM

Post-LOE

amoxicillin and clavulanate potassium

Teva

ANDAORALTABLET

Approved

Oct 2002

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium) by Teva is tablets, amoxicillin and clavulanate potassium for oral suspension, and amoxicillin and clavulanate potassium tablets (chewable) are antibacterial drugs [see microbiology ()] . Approved for infections in adults, due to susceptible isolates of the designated bacteria in the conditions listed below: lower respiratory tract infections – caused by beta–lactamase–producing isolates of haemophilus influenzae, moraxella catarrhalis and 16 more indications. First approved in 2002.

Drug data last refreshed 21h ago

Mechanism of Action

tablets, amoxicillin and clavulanate potassium for oral suspension, and amoxicillin and clavulanate potassium tablets (chewable) are antibacterial drugs [see Microbiology ()] .

Indications (19)

infections in adults due to susceptible isolates of the designated bacteria in the conditions listed below: Lower Respiratory Tract Infections – caused by beta–lactamase–producing isolates of Haemophilus influenzae

Worked on AMOXICILLIN AND CLAVULANATE POTASSIUM at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.